Fundies.
English

ImmunityBio, Inc.

EDGAR
IBRX Current report (8-K) · filed 2026-10-14

Annual consolidated revenue for 2025: about USD 113.3M, using the latest reported figures. The previous period, 2024, was about USD 14.75M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

51.2 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

-120.41%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -61697000 USD Source
  • Revenue: 51240000 USD Source

Operating cash flow

-66.5 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -141900000 USD Source
  • Operating Cash Flow: -75400000 USD Source

Free cash flow

-70 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -141900000 USD Source
  • Operating Cash Flow: -75400000 USD Source
  • Capital Expenditure: 5292000 USD Source
  • Capital Expenditure: 1776000 USD Source
Cash and cash equivalents
75.7 million USD Source
Exact value

75670000 USD

Long-term debt including current maturities
Not available
Shares outstanding
1.05 billion shares Source
Exact value

1053221645 shares

Reported share-count change

15.03% · 138 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 915625053 shares · 2025-06-30· Source
  • 1053221645 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

166 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 32061000 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 113288000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 75003000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 44206000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 51240000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-992 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -67253000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -351398000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -289454000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -632782000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -230378000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-281 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -234600000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -165651000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -304900000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -234600000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -75400000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -141900000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -75400000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

6.94 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 2943000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 2202000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 3846000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 2943000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 1776000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 5292000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 1776000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-288 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -234600000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -165651000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -304900000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -234600000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -75400000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -141900000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -75400000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 2943000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 2202000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 3846000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 2943000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 1776000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 5292000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 1776000 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-14.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 11 of 11 periods available· newest 2025-12-31
  • Operating income: 11 of 11 periods available· newest 2025-12-31
  • Net income: 11 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 11 of 11 periods available· newest 2025-12-31
  • Total assets: 11 of 11 periods available· newest 2025-12-31
  • Total liabilities: 11 of 11 periods available· newest 2025-12-31
  • Current assets: 11 of 11 periods available· newest 2025-12-31
  • Current liabilities: 11 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +668.3%

    Prior period

    USD 14.75 million

    –

    Current period

    USD 113.29 million

    –

    Exact inputs and evidence

    113288000 − 14745000 = 98543000 USD

    14745000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    113288000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 62.17 million

    Prior period

    −USD 413.56 million

    –

    Current period

    −USD 351.4 million

    –

    Exact inputs and evidence

    -351398000 − -413564000 = 62166000 USD

    -413564000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -351398000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 86.34 million

    Prior period

    −USD 391.24 million

    –

    Current period

    −USD 304.9 million

    –

    Exact inputs and evidence

    -304900000 − -391236000 = 86336000 USD

    -391236000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -304900000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -44.2%

    Prior period

    USD 6.89 million

    –

    Current period

    USD 3.85 million

    –

    Exact inputs and evidence

    3846000 − 6888000 = -3042000 USD

    6888000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    3846000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 113.29 million 100% of revenue
  • Operating costs Derived USD 369.32 million 326% of revenue
  • Operating income −USD 256.03 million −226% of revenue
  • Tax, interest and other Derived USD 95.37 million 84% of revenue
  • Net income −USD 351.4 million −310% of revenue

Cash

  • Operating cash flow −USD 304.9 million −269% of revenue
  • Capital expenditure USD 3.85 million 3.4% of revenue
  • Free cash flow Derived −USD 308.75 million −273% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Operating loss: operating costs were 283,055% of revenue.
  • 2017 Operating loss: operating costs were 220,367% of revenue.
  • 2018 Operating loss: operating costs were 209,438% of revenue.
  • 2019 Operating loss: operating costs were 7,196% of revenue.
  • 2020 Operating loss: operating costs were 36,609% of revenue.
  • 2021 Operating loss: operating costs were 35,462% of revenue.
  • 2022 Operating loss: operating costs were 146,474% of revenue.
  • 2023 Operating loss: operating costs were 58,340% of revenue.
  • 2024 Operating loss: operating costs were 2,434% of revenue.
  • 2025 Operating loss: operating costs were 326% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2016-01-01 – 2016-12-3144000 124544000 Derived -124500000 -3691000 Derived -120809000 -45153000 Derived
Source
2017 2017-01-01 – 2017-12-3145000 99165000 Derived -99120000 -2697000 Derived -96423000 -83595000 Derived
Source
2018 2018-01-01 – 2018-12-3147000 98436000 Derived -98389000 -2163000 Derived -96226000 -76483000 Derived
Source
2019 2019-01-01 – 2019-12-312202000 158453000 Derived -156251000 1526000 Derived -157777000 -156396000 Derived
Source
2020 2020-01-01 – 2020-12-31605000 221485000 Derived -220880000 971000 Derived -221851000 -173393000 Derived
Source
2021 2021-01-01 – 2021-12-31934000 331214000 Derived -330280000 16510000 Derived -346790000 -307982000 Derived
Source
2022 2022-01-01 – 2022-12-31240000 351538000 Derived -351298000 65269000 Derived -416567000 -415671000 Derived
Source
2023 2023-01-01 – 2023-12-31622000 362872000 Derived -362250000 220946000 Derived -583196000 -397341000 Derived
Source
2024 2024-01-01 – 2024-12-3114745000 358927000 Derived -344182000 69382000 Derived -413564000 -398124000 Derived
Source
2025 2025-01-01 – 2025-12-31113288000 369315000 Derived -256027000 95371000 Derived -351398000 -308746000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 113.3M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.122.4M91.8M61.2M30.6M0.0201620212025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Revenue44000
2017Revenue45000
2018Revenue47000
2019Revenue2202000
2020Revenue605000
2021Revenue934000
2022Revenue240000
2023Revenue622000
2024Revenue14745000
2025Revenue113288000

Revenue growth

Change in revenue from the same financial period one year earlier.

668.3% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4,958%3,605%2,252%899%-455%201620212025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2016Year over year-81.4%
2017Year over year2.3%
2018Year over year4.4%
2019Year over year4,585.1%
2020Year over year-72.5%
2021Year over year54.4%
2022Year over year-74.3%
2023Year over year159.2%
2024Year over year2,270.6%
2025Year over year668.3%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -226% 2025
Net margin -310.2% 2025
Free cash flow margin -272.5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.22,636%-59,420%-141,477%-223,534%-305,591%201620212025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2016Operating margin-282,954.5%
2017Operating margin-220,266.7%
2018Operating margin-209,338.3%
2019Operating margin-7,095.9%
2020Operating margin-36,509.1%
2021Operating margin-35,361.9%
2022Operating margin-146,374.2%
2023Operating margin-58,239.5%
2024Operating margin-2,334.2%
2025Operating margin-226%
2016Net margin-274,565.9%
2017Net margin-214,273.3%
2018Net margin-204,736.2%
2019Net margin-7,165.2%
2020Net margin-36,669.6%
2021Net margin-37,129.6%
2022Net margin-173,569.6%
2023Net margin-93,761.4%
2024Net margin-2,804.8%
2025Net margin-310.2%
2016Free cash flow margin-102,620.5%
2017Free cash flow margin-185,766.7%
2018Free cash flow margin-162,729.8%
2019Free cash flow margin-7,102.5%
2020Free cash flow margin-28,660%
2021Free cash flow margin-32,974.5%
2022Free cash flow margin-173,196.3%
2023Free cash flow margin-63,881.2%
2024Free cash flow margin-2,700.1%
2025Free cash flow margin-272.5%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -304.9M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.31.3M-82.2M-195.6M-309.1M-422.5M201620212025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Operating cash flow-38593000
2017Operating cash flow-48780000
2018Operating cash flow-63381000
2019Operating cash flow-152109000
2020Operating cash flow-171724000
2021Operating cash flow-274419000
2022Operating cash flow-337509000
2023Operating cash flow-366757000
2024Operating cash flow-391236000
2025Operating cash flow-304900000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -308.7M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.33.3M-87.3M-207.8M-328.4M-448.9M201620212025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Free cash flow-45153000
2017Free cash flow-83595000
2018Free cash flow-76483000
2019Free cash flow-156396000
2020Free cash flow-173393000
2021Free cash flow-307982000
2022Free cash flow-415671000
2023Free cash flow-397341000
2024Free cash flow-398124000
2025Free cash flow-308746000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

199.5% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.246%184%123%61%0%201620212025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2016Liabilities / assets7.6%
2017Liabilities / assets12.6%
2018Liabilities / assets19.8%
2019Liabilities / assets15.7%
2020Liabilities / assets153.5%
2021Liabilities / assets152%
2022Liabilities / assets224.1%
2023Liabilities / assets216.2%
2024Liabilities / assets227.5%
2025Liabilities / assets199.5%

Current assets to current liabilities

Current assets divided by current liabilities.

5.1× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.17.65×13.24×8.82×4.41×0.00×201620212025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2016Current assets / current liabilities16.34×
2017Current assets / current liabilities6.35×
2018Current assets / current liabilities3.26×
2019Current assets / current liabilities4.82×
2020Current assets / current liabilities1.64×
2021Current assets / current liabilities0.91×
2022Current assets / current liabilities0.28×
2023Current assets / current liabilities5.05×
2024Current assets / current liabilities3.36×
2025Current assets / current liabilities5.1×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 120.81 million
Exact value

Exact value: -120809000 USD

2016-01-01 – 2016-12-31: -120809000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 38.59 million
Exact value

Exact value: -38593000 USD

2016-01-01 – 2016-12-31: -38593000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 6.56 million
Exact value

Exact value: 6560000 USD

2016-01-01 – 2016-12-31: 6560000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 45.15 million
Calculation and evidence

-38593000 − 6560000 USD

Exact free cash flow: -45153000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 96.42 million
Exact value

Exact value: -96423000 USD

2017-01-01 – 2017-12-31: -96423000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 48.78 million
Exact value

Exact value: -48780000 USD

2017-01-01 – 2017-12-31: -48780000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 34.82 million
Exact value

Exact value: 34815000 USD

2017-01-01 – 2017-12-31: 34815000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 83.6 million
Calculation and evidence

-48780000 − 34815000 USD

Exact free cash flow: -83595000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 96.23 million
Exact value

Exact value: -96226000 USD

2018-01-01 – 2018-12-31: -96226000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 63.38 million
Exact value

Exact value: -63381000 USD

2018-01-01 – 2018-12-31: -63381000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 13.1 million
Exact value

Exact value: 13102000 USD

2018-01-01 – 2018-12-31: 13102000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 76.48 million
Calculation and evidence

-63381000 − 13102000 USD

Exact free cash flow: -76483000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 157.78 million
Exact value

Exact value: -157777000 USD

2019-01-01 – 2019-12-31: -157777000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 152.11 million
Exact value

Exact value: -152109000 USD

2019-01-01 – 2019-12-31: -152109000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.29 million
Exact value

Exact value: 4287000 USD

2019-01-01 – 2019-12-31: 4287000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 156.4 million
Calculation and evidence

-152109000 − 4287000 USD

Exact free cash flow: -156396000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 221.85 million
Exact value

Exact value: -221851000 USD

2020-01-01 – 2020-12-31: -221851000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 171.72 million
Exact value

Exact value: -171724000 USD

2020-01-01 – 2020-12-31: -171724000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.67 million
Exact value

Exact value: 1669000 USD

2020-01-01 – 2020-12-31: 1669000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 173.39 million
Calculation and evidence

-171724000 − 1669000 USD

Exact free cash flow: -173393000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 346.79 million
Exact value

Exact value: -346790000 USD

2021-01-01 – 2021-12-31: -346790000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 274.42 million
Exact value

Exact value: -274419000 USD

2021-01-01 – 2021-12-31: -274419000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 33.56 million
Exact value

Exact value: 33563000 USD

2021-01-01 – 2021-12-31: 33563000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 307.98 million
Calculation and evidence

-274419000 − 33563000 USD

Exact free cash flow: -307982000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 416.57 million
Exact value

Exact value: -416567000 USD

2022-01-01 – 2022-12-31: -416567000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 337.51 million
Exact value

Exact value: -337509000 USD

2022-01-01 – 2022-12-31: -337509000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 78.16 million
Exact value

Exact value: 78162000 USD

2022-01-01 – 2022-12-31: 78162000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 415.67 million
Calculation and evidence

-337509000 − 78162000 USD

Exact free cash flow: -415671000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 583.2 million
Exact value

Exact value: -583196000 USD

2023-01-01 – 2023-12-31: -583196000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 366.76 million
Exact value

Exact value: -366757000 USD

2023-01-01 – 2023-12-31: -366757000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 30.58 million
Exact value

Exact value: 30584000 USD

2023-01-01 – 2023-12-31: 30584000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 397.34 million
Calculation and evidence

-366757000 − 30584000 USD

Exact free cash flow: -397341000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 413.56 million
Exact value

Exact value: -413564000 USD

2024-01-01 – 2024-12-31: -413564000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 391.24 million
Exact value

Exact value: -391236000 USD

2024-01-01 – 2024-12-31: -391236000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 6.89 million
Exact value

Exact value: 6888000 USD

2024-01-01 – 2024-12-31: 6888000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 398.12 million
Calculation and evidence

-391236000 − 6888000 USD

Exact free cash flow: -398124000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 351.4 million
Exact value

Exact value: -351398000 USD

2025-01-01 – 2025-12-31: -351398000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 304.9 million
Exact value

Exact value: -304900000 USD

2025-01-01 – 2025-12-31: -304900000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.85 million
Exact value

Exact value: 3846000 USD

2025-01-01 – 2025-12-31: 3846000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 308.75 million
Calculation and evidence

-304900000 − 3846000 USD

Exact free cash flow: -308746000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

91 filings · 3,759 latest values · 3,759 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001326110, 1326110, IBRX, NK, edgar:1326110

Also known as Conkwest, Inc., IMMUNITYBIO, INC., IMMUNITYBIO, INC., ImmunityBio, Inc., NANTKWEST, INC., NantKwest, Inc., ZelleRx Corp